Accessibility Menu
 
Bloomios logo

Bloomios

(OTC) BLMS

Current Price$0.00
Market Cap$6,400
Since IPO (2004)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Bloomios Financials at a Glance

Market Cap

$6,400

Revenue (TTM)

$8.23M

Net Income (TTM)

$40.31M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Price

$0.00

Volume

90

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

BLMS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bloomios

Industry

Pharmaceuticals

CEO

Michael Hill

Headquarters

Santa Barbara, CA 93101, US

BLMS Financials

Key Financial Metrics (TTM)

Gross Margin

37%

Operating Margin

-68%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

4%

Return on Assets

-53%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.40K

Shares Outstanding

64.47M

Volume

90

Avg. Volume

1.429

Financials (TTM)

Gross Profit

$2.23M

Operating Income

$4.14M

EBITDA

$12.37M

Operating Cash Flow

$6.33M

Capital Expenditure

$24.23K

Free Cash Flow

$6.35M

Cash & ST Invst.

$0.00

Total Debt

$22.48M

Bloomios Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2023YOY CHG

Revenue

$682.04K

-43.1%

Gross Profit

$315.74K

-47.4%

Gross Margin

46.29%

N/A

Market Cap

$6.40K

N/A

Market Cap/Employee

$2.13K

N/A

Employees

3

N/A

Net Income

$26.03M

-1139.1%

EBITDA

$25.18M

-1282.7%

Quarterly Fundamentals

Name
Q3 2023YOY CHG

Net Cash

$24.58M

-347.2%

Accounts Receivable

$344.31K

+320.0%

Inventory

$0.00

-100.0%

Long Term Debt

$269.06K

+79.4%

Short Term Debt

$24.31M

+354.1%

Return on Assets

-52.95%

N/A

Return on Invested Capital

3.54%

N/A

Free Cash Flow

$1.17M

-351.5%

Operating Cash Flow

$1.17M

-352.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CENBFCEN Biotech, Inc.
$0.00+0.00%
WOWUWOWI, Inc.
$0.00+0.00%
SAGDSouth American Gold Corp.
$0.00+0.00%
STABStatera Biopharma, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%
NIONio
$5.91-0.08%

Questions About BLMS

What is the current price of Bloomios?

Bloomios is trading at $0.00 per share.

What is the 52-week range for Bloomios?

Over the past 52 weeks, Bloomios has traded between $0.00 and $0.00.

How much debt does Bloomios have?

As of the most recent reporting period, Bloomios reported total debt of $22.48M.

How much cash does Bloomios have on hand?

Bloomios reported N/A in cash and cash equivalents in its most recent financial results.

What is Bloomios’s dividend yield?

Bloomios does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.